A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating (Q33434046)

26 July 2017

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating (English)

1 reference

randomized controlled trial

26 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

irritable bowel syndrome

1 reference

8

Zinsmeister AR

1 reference

26 July 2017

Kim HJ

1

1 reference

26 July 2017

Vazquez Roque MI

2

1 reference

26 July 2017

Camilleri M

3

1 reference

26 July 2017

Stephens D

4

1 reference

26 July 2017

Burton DD

5

1 reference

26 July 2017

Baxter K

6

1 reference

26 July 2017

Thomforde G

7

1 reference

26 July 2017

1 October 2005

1 reference

Neurogastroenterology and Motility

26 July 2017

1 reference

26 July 2017

17

1 reference

26 July 2017

5

1 reference

26 July 2017

687-696

1 reference

Diagnosis and therapy of irritable bowel syndrome.

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Gut flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00695.X

10.1111/J.1365-2982.2005.00695.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference